A 48-week, Randomized Controlled Trial of Doravirine for Individuals with HIV and Obesity on Integrase Inhibitors and Tenofovir Alafenamide: The Do IT Study (ACTG A5391). uri icon

authors

  • Koethe, John R
  • Debroy, Paula
  • Bennet, Jaclyn Ann
  • O'Halloran, Jane
  • Han, Win Min
  • Alli, Oladapo
  • Leonard, Michael
  • Gulick, Roy M
  • Lake, Jordan E
  • Kantor, Amy
  • Smeaton, Laura
  • Kristine Erlandson, MD
  • Moran, Laura
  • Belaunzaran-Zamudio, Pablo
  • Landay, Alan
  • Campo, Rafael E

publication date

  • March 18, 2026